Diagnostic News and Research

RSS

Topera Medical to showcase RhythmView system at HRS annual meeting

Topera Medical today announced that its FDA-cleared RhythmView 3D mapping and diagnostic system will be featured in 16 scientific presentations at the 33rd Annual Scientific Sessions of the Heart Rhythm Society (HRS), May 9-12 in Boston.

4 May 2012

Cardiac testing important for lung disease prognosis, treatment

A simple test for heart disease risk can go a long way toward determining the long-term prognosis for people with chronic obstructive pulmonary disease, according to UC Irvine researchers.

3 May 2012

Non-invasive imaging technique measures specific brain chemical changes

Alzheimer's disease (AD) is a major neurodegenerative disorder that affects millions of people worldwide. New and accurate techniques for early diagnosis are critical. Pravat K. Mandal, PhD, and his colleagues have developed a completely non-invasive brain imaging technique to measure specific brain chemical changes. This provides a signature of the early stages of AD from the hippocampal region of the brain.

3 May 2012

Cone beam CT superior to mutidetector CT for detecting superior semicircular canal dehiscence

Cone beam CT is superior to mutidetector CT for detecting superior semicircular canal dehiscence or the so called third window (a small hole in the bony wall of the inner ear bone that can cause dizziness and hearing loss) and it uses half the radiation dose, a new study shows.

3 May 2012

Brain imaging for stroke is still occurring too slowly at many hospitals

The mantra in stroke care is "time is brain." With each passing minute more brain cells are irretrievably lost and, because of this, timely diagnosis and treatment is essential to increase the chances for recovery. While significant strides have been made to improve the response time of caregivers, a new study shows that a critical step in the process - imaging of the brain to determine the nature of the stroke - is still occurring too slowly at too many hospitals.

3 May 2012

Johnson & Johnson announces acquisition of Bioseal

Johnson & Johnson (China) Investment Ltd. today announced it has acquired Guangzhou Bioseal Biotechnology Co., Ltd. (Bioseal) a privately held biopharmaceutical company specializing in the design, development and commercialization of a porcine plasma-derived biologic product for controlling bleeding during surgery.

3 May 2012

Women with benign breast biopsies do not need follow-up at six months

Contrary to current guidelines, women with benign breast biopsies do not need follow-up at six months; they may not need close surveillance at all, a new study shows.

3 May 2012

JAD honors Norwegian scientist with 2012 Alzheimer Award

Anders L-nneborg, PhD, has been chosen as the recipient of the 2012 Alzheimer Award presented by the Journal of Alzheimer's Disease in recognition of his outstanding work on the detection of early Alzheimer's disease.

3 May 2012

Math models can be useful tools for study of cancer progression

Using mathematical models, researchers in the Integrated Mathematical Oncology (IMO) program at Moffitt Cancer Center are focusing their research on the interaction between the tumor and its microenvironment and the "selective forces" in that microenvironment that play a role in the growth and evolution of cancer.

3 May 2012

Study assesses perceived impact of CMS payment policy on hospital infection prevention efforts

The 2008 decision by the Centers for Medicare & Medicaid Services (CMS) to cease additional reimbursement to hospitals for certain healthcare-associated infections (HAIs) has led to enhanced focus on infection prevention and changes in practice by front-line staff, according to a national survey of infection preventionists published in the May issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

2 May 2012

Endocrine Society and its Hormone Health Network release ‘Menopause Map’

Women going through menopause now have a first-of-its-kind interactive guide to help them better understand their menu of treatment options, including whether hormone therapy may be right for them. The Endocrine Society and its Hormone Health Network today released the "Menopause Map," an online tool to help women and their doctors discuss which hormonal and non-hormonal treatment options would be most effective and safe to relieve the sometimes debilitating symptoms of menopause.

2 May 2012

REACH Health launches enhanced telemedicine clinical platform

REACH Health, Inc., a leading provider of telemedicine technology solutions for health systems, today announced the launch of its enhanced telemedicine clinical platform, REACH Access.

2 May 2012

SCPC accredits Porter Adventist Hospital as Chest Pain Center

The Society of Chest Pain Centers (SCPC) recently awarded Porter Adventist Hospital full accreditation status as a Chest Pain Center.

2 May 2012

Lower radiation dose due to dedicated pediatric imaging department for CT scans

The use of a dedicated pediatric imaging department (with dedicated pediatric computed tomography (CT) technologists) for pediatric CT scans significantly reduces the radiation dose delivered to the patient, according to a study in the May issue of the Journal of the American College of Radiology.

2 May 2012

LifeCodexx completes PraenaTest clinical study on trisomy 21

LifeCodexx today announced the successful completion of the clinical validation study of its noninvasive test method for the detection of fetal trisomy 21 from maternal blood using Next Generation sequencing.

2 May 2012

IDEX announces acquisition of ERC

IDEX Corporation announced today that it has acquired ERC from MH Capital Partners II, L.P.

2 May 2012

FDA clears Great Basin’s first C. diff molecular diagnostic test

Great Basin Corporation, a privately-held life sciences company developing sample-to-result molecular diagnostic solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for its first molecular diagnostic test for Clostridium difficile.

2 May 2012

Trovagene completes PCR assay development for detection of K-RAS mutations

Trovagene, Inc., a developer of trans-renal molecular diagnostics, announced today that the Company has successfully completed the analytical development of digital PCR assays for the detection of the most prevalent K-RAS mutations, which are, according to recent estimates, observed in more than 90% of pancreatic cancers, and in 23% of all solid tumors.

30 Apr 2012

JCO publishes Syndax erlotinib-entinostat Phase 2 study for advanced non-small cell lung cancer

Syndax Pharmaceuticals, Inc., a late-stage oncology company focused on the clinical development of epigenetic therapies in solid tumors, announced that previously reported results from ENCORE 401, a randomized, placebo controlled Phase 2 study of erlotinib with or without entinostat in advanced non-small cell lung cancer patients were published in the Journal of Clinical Oncology (JCO).

30 Apr 2012

Hologic enters definitive agreement to acquire Gen-Probe

Hologic, Inc. and Gen-Probe Incorporated today announced that their Boards of Directors have unanimously approved a definitive agreement under which Hologic will acquire all of the outstanding shares of Gen-Probe for $82.75 per share in cash, or a total enterprise value of approximately $3.7 billion.

From Hologic, Inc. 30 Apr 2012